Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 3 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Breast Neoplasms 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Neoplasm Metastasis 3 Stomatitis 2 Stomach Neoplasms 2 Leukemia, Myeloid, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Trauma, Nervous System 1 Thromboembolism 1 Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1 Lipoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Intracranial Hemorrhages 1

Interventions

Gemcitabine 205 130-nm albumin-bound paclitaxel 84 Albumin-Bound Paclitaxel 57 pembrolizumab 43 Fluorouracil 41 Leucovorin 34 Oxaliplatin 33 Capecitabine 25 Nivolumab 22 Irinotecan 19 Bevacizumab 17 Paclitaxel 16 Cyclophosphamide 15 Cetuximab 15 Taxes 13 Erlotinib Hydrochloride 13 Drug Therapy 13 Carboplatin 12 irinotecan sucrosofate 11 Injections 10 Cisplatin 9 fludarabine 8 ALT-803 8 spartalizumab 7 olaparib 7 avelumab 7 Pemetrexed 7 Docetaxel 7 ruxolitinib 6 TH 302 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pancreatic Neoplasms × Saline Solution × Clear all

NCT01956812 2021-08-16

PANCRIT®-1

Gilead Sciences

Phase 3 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡